Vanguard's Value ETF Is Beating Its Growth ETF in 2026. That Has Happened Only 3 Times Since 2012.

And then came 2022, when value won by losing less. The value fund dipped around 2% in a year the growth fund sank about 33%.

C Q3 Deep Dive: Services and Wealth Drive Growth Amid Market Caution

Global financial services giant Citigroup (NYSE:C) reported Q3 2026 results exceeding the market’s revenue expectations, with ...

AI boom drives record sales at Dutch tech giant ASML

Dutch technology giant ASML, which makes cutting-edge machines to make semiconductor chips, said Wednesday that the huge demand for AI had powered record sales and strong profits, and vowed to scale ...

Global Life Sciences IT Market Opportunities and Strategies to 2035 | Capitalize on AI, Cloud and Bioinformatics as IQVIA, Oracle, Accenture, Veeva Systems and SAP Target $82.24B

Boost ROI via AI/cloud and quantum tools, SaaS, integrated data ecosystems, digital channels, value-based contracts, targeted promotion, partnerships and user training.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

Global Cell-Based Assays Market Report 2026-2030 | Secure Share in the $54.79 Billion Market Growing at 13.3% as Promega, Bio-Rad, PerkinElmer, and Danaher Scale AI Automation

Rad, PerkinElmer, Abcam and Enzo Life Sciences. Profiles cover cell-based assay products, technologies, applications, end users and trends.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Cell Based Assays ...

Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics

Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE ...
Opinion

Palliser Capital Calls on Recordati’s Directors to Clarify Publicly Whether They Unanimously Recommend the Revised €53.00 CVC-Led Offer

Palliser Capital ("Palliser"), a shareholder of Recordati S.p.A. ("Recordati" or the "Company") has today written to Recordati’s Board seeking public clarification of the independent directors’ ...

Sapreme Therapeutics announces oral presentation of new preclinical data on lead Duchenne muscular dystrophy candidate SPM-2551 at OTS 2026

SPM-2551 demonstrated robust and durable pharmacological activity following a single low-dose administration in preclinical Duchenne muscular dystrophy (DMD) modelsData support Sapreme's proprietary ...

AYODHYA 2.0: Faith, Tourism and the Next Investment Capital

Liases Foras, an independent real estate research firm, has released its latest report titled 'Ayodhya 2.0: Faith, Tourism and the New Investment Capital', examining the city's rapid evolution ...
Yahoo Finance

Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ® (daridorexant) Across Eight Asia-Pacific M…

Synmosa to lead regulatory approvals, market access, distribution and sales in Singapore, Thailand, Indonesia, Malaysia, the ...

SciBase secures first payer coverage with Highmark, marking a major commercial inflection point

SciBase Holding AB ("SciBase") (STO: SCIB) a leader in advanced technology for the detection and prevention ofskin disease, announced today that Nevisense has received its first positive medical ...

Cathay FHC Enters "Agent First" Phase: 2026 Cathay Technology Conference Draws Nearly 7,000 Registrants, Unveils "AI Digital Colleague" Pilots, and Focuses on Autonomous ...

Cathay Financial Holdings (Cathay FHC) recently hosted its 2026 Cathay Technology Conference, one of Taiwan's flagship fintech events, as the company marked the 10th anniversary of its digital ...